Project Description

Biography:

Emma Fertani obtained her Master’s Degree in Biological Engineering from the National Institute of Applied Sciences of Toulouse (France) in 2024 and completed an exchange semester program in Biomedical Engineering at National Cheng Kung University (Taiwan).

During her studies, she conducted research at three institutions or companies: first, in molecular biology and microbiology at CNRS (French National Center for Scientific Research); second, at the mRNA Center of Sanofi, where she gained experience in both fundamental and applied research; and finally, she moved to Boston to complete her end-of-study internship at Brigham and Women’s Hospital (Harvard Medical School, USA), working on a cell-based immunotherapy for glioblastoma.

Motivated by the urgent need to improve cancer patients’ outcomes, Emma progressively oriented her career toward oncology research. She is now starting her PhD at Cancer State Therapeutics and in the laboratory of Prof. Cédric Blanpain, aiming to unravel the role of NR2F family members in cancer and metastasis.

Emma is thrilled to join Adaptmet, an ambitious and purpose-driven network that brings together excellent scientists and highly motivated students, all working to tackle metastasis from diverse perspectives. She believes that this collaborative environment will accelerate scientific discoveries, deepen understanding of the mechanisms driving metastatic progression, and help translate research into effective therapies.